ANNA SCOTT: Open Payments
NPI 1942852157 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,491 in 208 payments from 22 companies in 2025. Trend: 2023 $4,162 · 2024 $3,328 · 2025 $4,491
Food & beverage: $4,419Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $748 |
| UCB, Inc. | 15 | $426 |
| LEO Pharma Inc. | 10 | $338 |
| Galderma Laboratories, L.P. | 29 | $331 |
| Regeneron Healthcare Solutions, Inc. | 10 | $295 |
| Amgen Inc. | 13 | $248 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $241 |
| GENZYME CORPORATION | 10 | $236 |
| Novartis Pharmaceuticals Corporation | 9 | $219 |
| Organon LLC | 13 | $216 |
Products named: RINVOQ, DUPIXENT, Bimzelx, OTEZLA, SKYRIZI, NEMLUVIO, OPZELURA, COSENTYX.
Industry payments across SC — which companies pay providers there.
